Honeywell Aerospace (HONA) Q2 2026 Earnings Call Transcript

Honeywell Aerospace reported Q2 net sales of $4.52B (+5% YoY) but cut adjusted EBIT guidance by citing supply-chain bottlenecks, with adjusted EBIT of $1.0B (-7% YoY) and adjusted EPS of $1.87 (-32% YoY) including a ~$50M inventory obsolescence charge. The company revised 2026 organic sales growth to 4%–5% (down from 7%–9%) while maintaining 2H free cash flow of $1.0B–$1.5B and raising pro forma adjusted EBIT guidance to $4.35B–$4.45B. Management emphasized strong demand and an 8% rolling order increase, but warned supply-side investments (multisourcing/in-sourcing and supplier tooling) will dampen near-term results, with expected output recovery driving stronger 2027 growth.

Analysis

This reads like an execution reset, not a demand reset. The market will likely punish HONA near-term because the stock is now a pure-play aerospace story and pure-plays get no forgiveness when management has to admit the bottleneck is self-inflicted; the multiple should stay capped until investors see at least two clean quarters of sequential output acceleration. In the next 1-3 months, the key driver is whether the company can translate order strength into billings without another mix drag; if not, earnings revisions will keep drifting lower even if backlog remains healthy.

The second-order winner is the broader aerospace supply chain: castings, forgings, bearings, machining, and tooling vendors should see incremental demand as HONA pushes more capex into supplier capacity. Competitors with better execution and less mechanical-supply exposure, especially RTX and GE Aerospace, can look comparatively cleaner because they are not carrying the same near-term credibility discount. A more subtle beneficiary is any OEM/customer who can substitute away from HONA on future selectable content if qualification windows open, but that is a multi-year effect rather than a quarter-to-quarter trade.

Contrarian view: the consensus may be overstating how much demand is actually at risk. The bigger issue is timing—revenue is being pushed right, not obviously lost—so the 6-18 month setup could improve sharply if the supplier tooling spend works and past-due converts. What would falsify the bearish near-term thesis is a Q3/Q4 update showing output growth stepping above the current run-rate, no repeat of inventory charges, and evidence that aftermarket mix is recovering rather than being cannibalized by OE allocations.

Key Decisions for Investors

• Short HONA into any post-earnings bounce for a 1-3 month trade; thesis is continued multiple compression until management proves sequential output improvement. Cover if Q3/Q4 output growth materially exceeds the current ~4% run-rate or if backlog starts converting faster than expected.
• Relative-value pair: long HON / short HONA for the next 3-6 months. HON should benefit from being less exposed to this specific supply-chain execution overhang, while HONA remains burdened by capex and mix pressure.
• Do not chase HONA on the long side until there are two datapoints confirming supply-chain recovery; the cleaner entry would be after a second-quarterly print with no new guide cut and visible improvement in aftermarket mix.
• Set a watch item on aerospace supply-chain names tied to castings/forgings/tooling as secondary beneficiaries of HONA's capex cycle; if those vendors report accelerating order intake over the next 1-2 quarters, it would validate the operating thesis.